Vanda Pharmaceuticals (NASDAQ: VNDA) reported Q3 EPS of $0.13, $0.06 better than the analyst estimate of $0.07. Revenue for the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE